New Request for Applications for FDA Orphan Products Clinical Trials Grants Program

The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce a new funding opportunity for the Orphan Products Grants Program to support clinical trials for rare diseases and conditions.  The purpose of this funding opportunity announcement is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions.

Through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development. 

Application due date is October 21, by 11:59 pm ET.